Delivery Order SPE2DB22D9353-SPE2DB24FX1UD
Award Date 3/5/24
Potential Completion Date 3/26/24
Potential Value $20K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product, at a ceiling value of $4,974.44. The contract has a firm fixed price pricing type and an ultimate completion date of June 6, 2024. This award is associated with a larger indefinite delivery contract (IDC) between...
- This is a firm fixed-price delivery order for $25,106.30 awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a prescription pharmaceutical product. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to issue delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product, with a ceiling value of $12,324.60 and a period of performance through September 6, 2024. The award is part of a larger indefinite delivery contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA under the...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The contract is for the delivery of EXPAREL 266 MG/20 ML VIAL 20ML, with a potential value of $9,948.88 and a completion date of March 13, 2024. The contract has no set-aside designation. This delivery order is issued against DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with DLA, contract 4600082013 under the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of EXPAREL 266 MG/20 ML VIAL 20ML. The firm fixed-price contract has a ceiling value of $15,063.78 and an ultimate completion date of May 16, 2025. DMS Pharmaceutical Group Inc. is the prime contractor and there are no major subcontractors listed. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The firm fixed-price contract is valued at $14,923.32 and has a completion date of May 22, 2024. It is not associated with a set-aside program. The contract is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) with...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $5,711.28 contract is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product, to support the medical supply needs of military healthcare facilities. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program,...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business, for the supply of the pharmaceutical product EXPAREL 266 MG/20 ML VIAL 20ML. The contract has a ceiling value of $24,872.20 and an ultimate completion date of April 24, 2024. It is a Firm Fixed Price contract, with no set-aside designation. This Delivery Order is issued against DMS Pharmaceutical Group's larger Indefinite Delivery Vehicle...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for EXPAREL 266 MG/20 ML VIAL 20ML, with a ceiling value of $49,855.15 and an ultimate completion date of April 15, 2022. The award is made under a larger indefinite delivery contract (IDC) with the DLA valued at up to $499,999,999, which allows the DLA to issue delivery...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $12,057.76, is for the delivery of EXPAREL 133 MG/10 ML VIAL 10ML, a specialized pharmaceutical product. The contract has an ultimate completion date of April 28, 2025 and is not associated with any set-aside designations. DMS Pharmaceutical Group Inc. holds a significant single-award...